HIGHFIELD SURGERY
HOLTDALE APPROACH, LEEDS
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 114 | 123 | 92.7% | |
| STROKE 9 | 2006 | 116 | 121 | 95.9% | |
| Stroke 12 | 2007 | 111 | 121 | 91.7% | |
| Stroke 12 | 2008 | 105 | 113 | 92.9% | |
| Stroke 12 | 2009 | 104 | 113 | 92.0% | |
| Stroke 12 | 2010 | 97 | 106 | 91.5% | |
| STROKE 12 | 2011 | 92 | 100 | 92.0% | |
| STROKE 12 | 2012 | 93 | 99 | 93.9% | |
| STROKE 12 | 2013 | 90 | 95 | 94.7% | |
| STIA007 | 2014 | 96 | 96 | 100.0% | |
| STIA007 | 2015 | 101 | 103 | 98.1% | |
| STIA007 | 2016 | 108 | 109 | 99.1% | |
| STIA007 | 2017 | 121 | 123 | 98.4% | |
| STIA007 | 2018 | 107 | 107 | 100.0% | |
| STIA007 | 2019 | 103 | 104 | 99.0% | |
| STIA007 | 2020 | 103 | 105 | 98.1% | |
| STIA007 | 2021 | 94 | 99 | 94.9% | |
| STIA007 | 2022 | 93 | 94 | 98.9% | |
| STIA007 | 2023 | 99 | 101 | 98.0% |
